20\m=.\9ng/ml) to suppress ovulation. However, the extent of suppression of ovulation did not correlate with the serum LH levels < 5 ng/ml. The incidence ofovulation induced by the intrinsic LH-RH activity of some of these analogues was similar to or greater than that resulting from administration of LH-RH plus analogue, suggesting that the activity of LH-RH itself was eliminated by pretreatment with the analogues.
Introduction
Many attempts have been made to produce analogues of LH-RH which are able to bind to pituitary receptor sites but are devoid of gonadotrophin-releasing activity. Such analogues would compete with endogenous LH-RH, preventing its action, and, might, therefore, provide a new means of contraception. Several analogues based on the original decapeptide sequence have been synthesized and found to have weak but significant inhibitory properties (Vilchez-Martinez et ai, 1974a) . However, it was the discovery of several agonistic analogues of LH-RH that were far more potent than the natural hormone that enabled a variety of relatively strongly active antagonistic peptides to be developed with structures based on the super-active analogues (Coy et ai, 1973 (Coy et ai, , 1974 VilchezMartinez et ai, 1974b; de la Cruz et ai, 1975 de la Cruz et ai, , 1976a Corbin & Beattie, 1975) . Most of these ana¬ logues, however, possess residual inherent LH-RH activities, which may overcome their LH releaseinhibiting activities, resulting only in partial blockade or no blockade of ovulation in animals. In the present study, an attempt was made, by examining effects on LH-RH-induced ovulation in rats and hamsters under a variety of conditions, to explore the most effective ways of administering some of these compounds to maximize their anti-ovulatory activity and minimize their inherent LH-RH activity.
Materials and Methods
Analogues. The (Vilchez-Martinez et ai, 1974a, b; Coy et ai, 1973 Coy et ai, , 1974 . They were dissolved in about 100 µ propylene glycol and then diluted with 0-9% (w/v) NaCl to give an appropriate concentration (Vehicle 1). Some of the peptides were dissolved in 150 µ benzyl alcohol : ethanol (2:1 v/v) and then diluted with sesame oil (Vehicle 2). Each animal received 0-2 ml of this solution for a small dose or 1 ml for a large dose, since some analogues were not very soluble.
Golden hamsters (Lake View Hamsters Colony) and adult female rats (Charles River CD strain) were used throughout the study. They were maintained in an animal house equipped with controlled temperature and illumination (14 hr light from 05.00 to 19.00 hours) and were given free access to Purina laboratory chow and tap water.
Hamsters. The animals were examined every morning for a vaginal discharge as described by Ward (1946) (1972) . Coeffi¬ cients of within-assay variation were 7-5% and 3-7 ng/ml and 3-8% and 20 ng/ml. The sensitivity derived from the median variance ratio was 0-15 ng. Between-assay variance was 17-8% and 10-7 ng/ml in 7 assays.
Statistical analysis. Ovulation response was expressed by binomial data such as 1 for ovulation and 0 for non-ovulation, and these binomial data were subjected to analysis of variance (Hsu & Feldt, 1969; Seeger & Gabrielson, 1968) and then to Duncan's new multiple range test (NMR test) (Steel & Torrie, 1960) . The data of the hamster experiment (Table 1) and the second experiment with rats (Table 3) were subjected to one-way analysis of variance, and of the first experiment with rats (Table 2) to two-way analysis of variance. The mean +S.E.M. number of eggs ovulated by the rats in each group was calculated and compared with the others using the NMR test. The significance of differences among mean LH levels was also determined by using Duncan's NMR test.
Results

Hamster experiments
The anti-ovulatory effects of Peptides 1, 2 and 4 in golden hamsters are shown by the results in Table 1 . Analysis of variance indicated that the effect of treatments was highly significant (P < 001). Peptide 1 in Vehicle 1 (Group 2) did not exhibit any intrinsic ovulation-inducing activity and only one hamster in each of Groups 4 and 7 failed to ovulate when LH-RH was also given, indicating that this analogue had an insignificant suppressive effect.
Peptide 2 did not show any intrinsic ovulation-inducing activity in Vehicle 1 (Group 8), but some activity was found with Vehicle 2 (Group 9). Significant suppression of ovulation occurred when the analogue, in either vehicle, was injected 60 min before LH-RH was given. 
Rat experiments
The ratio of analogue (400 µg in Vehicle 1) to LH-RH was 2666 :1 and the results with rats in which ovulation was blocked by Nembutal are shown in Table 2 . Analysis of variance indicated that the interaction between LH-RH and analogue was significant (P < 0002). All the analogues tested, Peptides 1, 2 and 5, showed some intrinsic ovulation-inducing activity in this test. Some suppression of LH-RH-induced ovulation was seen, but only the effect of Peptide 1 was significant. There were no differences in the mean numbers of eggs ovulated.
In the experiments in which Peptides 2, 3, 4 and 6 were tested ( (1973) . The serum LH values were not (except for those of Group 4) different from those in control Nembutal-blocked rats (Group 2), and there was no correlation between the LH levels and the anti-ovulatory activity of the analogue. At a single dose of 400 µg, Peptides 1, 2 and 5 exhibited considerable intrinsic activity (Table 2) . Corbin & Beattie (1975) also reported that Peptide 3 possessed agonistic as well as antagonistic activity, but the agonistic activity was not strong enough to induce ovulation in Nembutal-blocked pro-oestrous rats, even when the i.v. dose was as high as 100 µg.
Considerable suppression of serum LH levels was observed after injection of most of the analogues tested (Table 3) , but dose-response relationships appeared to be of the 'all-or-none' type. It appeared to be necessary to lower LH levels to 5 ng/ml to suppress ovulation : when LH levels were above 5 ng/ml ovulation occurred in all the rats. De la Cruz et ai (1976b) suggested that 11 % of the total LH released during the afternoon of pro-oestrus was sufficient to induce full ovulation in hamsters.
The fact that the ovulation number induced by the intrinsic LH-RH activities of 400 µg Peptides 1, 2 or 5 appeared to be similar to or greater than those resulting from combined administration of 150 ng LH-RH plus one of these analogues ( Table 2 ), indicates that the ovulatory activity of LH-RH itself was eliminated by pretreatment with the analogues.
